A carregar...

Hypoglycaemic effects of the novel antidiabetic agent repaglinide in rats and dogs

1. Repaglinide, a novel compound with a nonsulphonylurea structure, is currently being clinically tested as a therapeutic agent. In the present study, the hypoglycaemic effects of repaglinide in rats and dogs were investigated. 2. Whereas the R-enantiomer, AG-EE 624 ZW, showed only weak hypoglycaemi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mark, Michael, Grell, Wolfgang
Formato: Artigo
Idioma:Inglês
Publicado em: 1997
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1564864/
https://ncbi.nlm.nih.gov/pubmed/9283692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0701307
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!